Combinations of Bevacizumab With Immune Checkpoint Inhibitors in Renal Cell Carcinoma

Gao, X; McDermott, DF

McDermott, DF (reprint author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.

CANCER JOURNAL, 2018; 24 (4): 171

Abstract

Renal cell carcinoma (RCC) is characterized by aberrant angiogenic signaling and an immunogenic tumor microenvironment. Systemic therapies targeting v......

Full Text Link